课题基金 / 基金详情

The influence of the protease inhibitor cystatin C on the occurrence of age-related macular degeneratin: evaluation of secretion by RPE cells and of possible mechanisms for its inhibition

The influence of the protease inhibitor cystatin C on the occurrence of age-related macular degeneratin: evaluation of secretion by RPE cells and of possible mechanisms for its inhibition
蛋白酶抑制剂半胱氨酸蛋白酶抑制剂 C 对年龄相关性黄斑变性发生的影响:评估 RPE 细胞的分泌及其抑制的可能机制
批准号:
5244412
负责人:
Professor Dr. Gisbert Richard
金额:
$0.0万
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
2000
资助国家:
德国
项目状态:
已结题
起止时间:
1999-12-31 至 2002-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have previously shown that CST3 is genetically associated with exudative age-related macular degeneration (ARMD). In this study, we intend to correlate between the CST3 genotype and the levels of gene expression, as well as posttranslational processing of the CST3 gene product, the cysteine protease inhibitor cystatin C in retinal pigment epithelial (RPE) cells. Cystatin C is a strog inhibitor of cathepsin S, one of the most important proteases in RPE cells; it is involved in the proteolytic metabolic pathways of these cells. The exact ways by which genotype can influence the phenotype at the cellular level are unknown. This study was designed to determine possible influences of cystatin C on proteases including cathepsin S which has a high activity in RPE cells. By using the RPE tissue culture model, we will test possible associations of the allelic variants with advanced exudative ARMD, and thus address the molecular basis of the resulting phenotype. To pursue these objectives, we habe established a DNA bank derived from of l67 patients with advanced exudative ARMD and from 268 control subjects. Moreover, the methods of culturing RPE cells are established in our laboratory.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
  • 批准号:
    82371317
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    万杰清
  • 依托单位:
新生儿坏死性小肠结肠炎中去泛素化酶USP15调控ILC3分化损伤肠道粘膜屏障的致病机制研究
  • 批准号:
    82371711
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    吕志宝
  • 依托单位:
抑素蛋白(prohibitin)1调控蛋白酶激活受体(protease-activated receptor)1内化转运及降解的功能和机制
三角帆蚌丝氨酸蛋白酶(serine protease)基因的克隆、表达调控与功能研究
  • 批准号:
    31040083
  • 项目类别:
    专项基金项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2010
  • 负责人:
    肖调义
  • 依托单位: